We propose a novel technical, regulatory, and cultural solution to support research on COVID- 19 and establish the open infrastructure required to respond to the next pandemic: ICEES+ COVID-19. The proposed work will build on the prior work that our team has been engaged with as part of the Biomedical Data Translator program (?Translator?), funded by the National Center for Advancing Translational Sciences (NCATS), to research and develop the Integrated Clinical and Environmental Exposures Service (ICEES). ICEES represents a unique, disease-agnostic framework and approach to support open sharing of and research on sensitive patient data that have been integrated at the patient and visit level with public exposures data. Importantly, ICEES has been validated in the context of our initial driving use case on asthma. We will extend this effort to instantiate an ICEES+ COVID-19 open infrastructure, focused on patients at UNC Health who have been tested (positive or negative) for COVID-19. The proposed work will leverage not only our prior Translator work, but also new work that our team has been engaged with as part of the NCATS Center for Data to Health (CD2H) National Covid Cohort Collaborative (N3C). Indeed, the North Carolina Translational and Clinical Sciences Institute (home to UNC?s CTSA) was selected by CD2H leadership to lead the technical implementation of significant portions of the N3C initiative. We will adopt the N3C COVID-19 consensus phenotype for the proposed work and extend the captured data fields to include relevant data fields that were intentionally excluded by the N3C collaborative in their effort to promote uniformity and participation, but are available via our local clinical data warehouse, such as temperature, oxygen saturation, isolation flags, and other potentially relevant clinical features (e.g., blood type). We also have partnered with investigators affiliated with the Environmental Polymorphisms Registry at the National Institute for Environmental Health Sciences and will be exposing data on their registry participants. Our overall aims are to develop and deploy ICEES+ COVID-19, apply ICEES+ COVID-19 to support research on COVID-19, and promote widespread use of ICEES+ COVID-19, largely through our engagement with the Translator program, CD2H N3C, and other large-scale collaboratives. A key aspect of the proposed work is that ICEES+COVID-19 will be open source, which will allow other institutions to rapidly adopt our approach and expose their data for open analysis of COVID-19 data by a much larger community. Collectively, the proposed work will catalyze efforts to respond to the COVID-19 pandemic and position society to be better prepared for the next one.
The proposed ?ICEES+ COVID-19? represents a novel technical, regulatory, and cultural solution to openly share otherwise sensitive patient data that have been integrated with public environmental exposures data of relevance to the COVID-19 pandemic. As an open framework and approach, ICEES+ COVID-19 will democratize research on COVID-19, serve as an exemplar for adoption elsewhere, and support preparedness for the next pandemic.
| James, Theodore W; Crockett, Seth D (2018) Management of acute pancreatitis in the first 72 hours. Curr Opin Gastroenterol 34:330-335 |
| Antoniak, Silvio; Tatsumi, Kohei; Schmedes, Clare M et al. (2018) Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity. J Mol Cell Cardiol 122:80-87 |
| Zègre-Hemsey, Jessica K; Burke, Larisa A; DeVon, Holli A (2018) Patient-reported symptoms improve prediction of acute coronary syndrome in the emergency department. Res Nurs Health 41:459-468 |
| Henderson, Kamal H; DeWalt, Darren A; Halladay, Jacquie et al. (2018) Organizational Leadership and Adaptive Reserve in Blood Pressure Control: The Heart Health NOW Study. Ann Fam Med 16:S29-S34 |
| Buse, John B; D'Alessio, David A; Riddle, Matthew C (2018) Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes? Diabetes Care 41:1560-1562 |
| Peery, Anne F; Shaheen, Nicholas J; Cools, Katherine S et al. (2018) Morbidity and mortality after surgery for nonmalignant colorectal polyps. Gastrointest Endosc 87:243-250.e2 |
| Buglak, Nicholas E; Batrakova, Elena V; Mota, Roberto et al. (2018) Insights on Localized and Systemic Delivery of Redox-Based Therapeutics. Oxid Med Cell Longev 2018:2468457 |
| Kinlaw, Alan C; Jonsson Funk, Michele; Conover, Mitchell M et al. (2018) Impact of New Medications and $4 Generic Programs on Overactive Bladder Treatment Among Older Adults in the United States, 2000-2015. Med Care 56:162-170 |
| Shah, Parth D; Calo, William A; Marciniak, Macary W et al. (2018) Service quality and parents' willingness to get adolescents HPV vaccine from pharmacists. Prev Med 109:106-112 |
| Khairat, Saif; Ottmar, Paige; Sleath, Betsy et al. (2018) Facilitating the Informed Consent Process Using Teleconsent: Protocol for a Feasibility and Efficacy Study. JMIR Res Protoc 7:e11239 |
Showing the most recent 10 out of 76 publications
